Delayed Discovery of Linezolid-Resistant, Vancomycin-Resistant Enterococcus faecium: Lessons Learned [3]

Clinical Infectious Diseases

Volumn 38, Issue 1, 2004, Pages 155-156

  Schwartz, Michael D ^a   Shive, Diana K ^a   Shaikh, Zakir Hussein A ^a  

^a METHODIST DALLAS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LINEZOLID; VANCOMYCIN;

AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; BACTERIAL INFECTION; BACTERIUM ISOLATE; BACTERIUM ISOLATION; CASE REPORT; DRUG SENSITIVITY; ENTEROCOCCUS FAECIUM; FEMALE; HOSPITALIZATION; HUMAN; INFORMATION PROCESSING; INTERPERSONAL COMMUNICATION; LETTER; MEDICAL PRACTICE; MEDICAL STAFF; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; PENICILLIN RESISTANCE; PRIORITY JOURNAL; UNITED STATES;

EID: 0346422345     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/380465     Document Type: Letter

References (2)

1. Rahim S, Pillai SK, Gold HS, et al. Linezolid-resistant, vancomycin-resistant Enterococcus faecium infection in patients without prior exposure to linezolid. Clin Infect Dis 2003; 36: e146-8.
2. Mutnick AH, Enne V, Jones RN. Linezolid resistance since 2001: SENTRY antimicrobial surveillance program. Ann Pharmacother 2003; 37: 769-74.